About
Technology
Issues
FAQ
Links
Official Page
Successful rechallenge in two patients with BRAF-V600-mutant melanoma who experienced previous progression during treatment with a selective BRAF inhibitor
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.